# CYCLOPHOSPHAMIDE

NDC: 68001-565
Generic name: cyclophosphamide
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230410

FDA application: NDA212501

## Active ingredients

- CYCLOPHOSPHAMIDE ANHYDROUS: 200 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-565"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-565
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0afd2cc7-09e6-481a-afea-9d2e3742da46